LCA partners with GRAIL, UCL, and ULCH on Newly Announced SUMMIT Study

2018-12-04T00:24:30+00:00December 4th, 2018|Hot Topics, News|

Monday, December 3, 2018 –Today, Lung Cancer Alliance, in collaboration with GRAIL, Inc., a healthcare company focused on the early detection of cancer, UCL (University College London) and University College London Hospitals National Health Service (NHS) Foundation Trust (UCLH) announced plans to initiate the SUMMIT study in early 2019. SUMMIT, which will be conducted in the United Kingdom, is a prospective, observational, longitudinal, cohort study designed to enroll approximately 50,000 men and women age 50 to 77 years who do [...]

Highlights from World Conference on Lung Cancer

2018-10-01T13:48:43+00:00September 27th, 2018|Events, Hot Topics, News|

This week, the LCA team attended the 19th Annual World Conference on Lung Cancer (September 23-26, 2018) in Toronto, Canada. Jennifer C. King, PhD, Director of Science and Research, gives us the scoop on some of the research and treatment breakthroughs, and how they impact you! https://youtu.be/Q2S7akrHUVQ SCREENING REDUCES MORTALITY! Results from the Dutch-Belgium Lung Cancer Screening trial (NELSON) showed that lung cancer screening significantly reduces lung cancer mortality. In this trial, which was more favorable than the National Lung [...]